Belite Bio, Inc

This study tests an experimental drug called tinlarebant in 429 adults with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. Participants receive either the drug or a placebo for about two years. The main goal is to see if the …

This study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes progressive vision loss. The goal is to see if the drug can slow the growth of damage in the back of the eye and preserve eyesight. Participants receive either the drug…